Synergy CHC (SNYR) Asset Writedowns and Impairment (2018 - 2024)
Synergy CHC (SNYR) posted quarterly Asset Writedowns and Impairment of $120565.0 for Q4 2024, down 47.36% year-over-year from $229027.0 in Q1 2024, and up 5123.54% quarter-over-quarter from -$2400.0 in Q2 2024.
Synergy CHC (SNYR) Asset Writedowns and Impairment (2018 - 2024) Analysis & Trends
Synergy CHC's Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $120565.0 for Q4 2024.
- In Q4 2024, Asset Writedowns and Impairment fell 47.36% year-over-year to $120565.0; the TTM figure through Dec 2024 stood at $125364.0 (changed N/A YoY), while the FY2025 annual figure was $2.3 million, up 1700.23% from the prior year.
- Asset Writedowns and Impairment for Q4 2024 stood at $120565.0, up from -$2400.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $229027.0 in Q4 2023, with the low at -$2400.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn |
| 10 | Synergy CHC | 945,032.04 | -1.85 Mn | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 120,565.00 |
| Dec 31, 2024 | 120,565.00 |
| Jun 30, 2024 | -2,400.00 |
| Jun 30, 2024 | -2,400.00 |
| Mar 31, 2024 | 7,199.00 |
| Mar 31, 2024 | 7,199.00 |
| Dec 31, 2023 | 229,027.00 |
| Dec 31, 2023 | 229,027.00 |
| Dec 31, 2019 | -1.92 Mn |
| Dec 31, 2019 | -1.92 Mn |
| Dec 31, 2018 | -924,068.00 |
| Dec 31, 2018 | -924,068.00 |